Faculty Information - Ryoei Hara

（Last updated : 2021-06-07 09:09:59）

Ryoei Hara
Department Kawasaki Medical School Kawasaki Medical School, Department of Urology,

Position Associate Professor

■ Journal

1.	2020	Outcomes of robot-assisted partial nephrectomy in the treatment of renal cell carcinoma at Kawasaki Medical School Hostiptal
2.	2019/03	Intra-abdominal desmoid tumor mimicking local recurrence of renal cell carcinoma after laparoscopic partial nephrectomy.
3.	2018	Male squirting: Analysis of one case using color Doppler ultrasonography
4.	2017/08	Long-term compliance and treatment failure of alpha1-blocker for patients with benign prostatic hyperplasia
5.	2016/11	Tadalafil for male lower urinary tract symptoms improves endothelial function
6.	2015/06	Practical application of color Doppler ultrasonography in patients with ejaculatory dysfunction
7.	2013/02	Long-term safety and efficacy of two different antimuscarinics, imidafenacin and solifenacin, for treatment of overactive bladder: a prospective randomized controlled study.
8.	2012/03	Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results.
9.	2012/01	Comparison of two different alpha1-adrenoceptor antagonists, tamsulosin hydrochloride and silodosin, in the treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A prospective randomized crossover study.
10.	2011/06	Retroperitoneoscopic Nephrectomy for Treatment of a Case of Left Single Ectopic Ureter Accompanied by Dysplastic Kidney
11.	2011/03	Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia
12.	2011/03	Penile verrucous carcinoma arising in HPV-negative condylomatous papules.
13.	2009/10	Does transection of the spermatic cord lower the incidence of inguinal hernia after radical retropubic prostatectomy?
14.	2009/10	The Effects of 3 Types of Alpha1-Adrenoceptor Blockers on Lower Urinary Tract Symptoms and Sexual Functions in Men with Benign Prostatic Hyperplasia
15.	2009/04	Is primary hormone therapy efficient for clinically localized prostate cancer in Japanese men?
16.	2009/04	Naftopidil and Propiverin Hydrochrolide for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: A prospective randomized controlled study
17.	2009/04	The effect of purified newly developed Botulinum neurotoxin type A in rat and human prostate
18.	2008/10	Ejaculatory dysfunction caused by new A1-blocker:analysis of human ejaculatory phenomenon using color doppler ultrasonigraphy
19.	2008/06	A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy.
20.	2008/02	Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy.
21.	2007/12	The experience of using dual lumen ureteral access sheath (AquaGuide TM)in ureteropyeloscopy
22.	2007/01	Pelvic Autonomic Nerve Mapping Around the Prostate by Intraoperative Electrical Stimulation With Simultaneous Measurement of Intracavernous and Intraurethral Pressure
23.	2006/01	Transperineal extended biopsy improves the clinically significant prostate cancer detection rate: a comparative study of 6 and 12 biopsy cores
24.	2005/04	A novel technique for approaching the endopelvic fascia in retropubic radical prostatectomy, based on an anatomical study of fixed and fresh cadavers
Display 5 items
Display all(24)

■ Presentation

1.	2020/07	90 Anti-inflammatory effect of IDO1 inhibition for acute inflammation in the prostate （Poster notice，General）
2.	2020/07	New pathological subtype of renal cell carcinoma in patients on long-term dialysis: acquired cystic disease-associated renal cell carcinoma （General）
3.	2020/07	Pathological analysis focused on inflammatory changes in bladder dysfunction following partial bladder outlet obstruction （Poster notice，General）
4.	2019/11/09	Preventive effect of tadalafil for chronic inflammation in the prostate （Speech，General）
5.	2019/10/19	Renal Cell Carcinoma in Japanese Patients with End-Stage Renal Disease （Poster notice，General）
6.	2019/10/19	Validation of the Prostate Imaging and Reporting Data System Version 2(PI-RADS v2) for the detection of prostate cancer in Japanese men with elevated PSA Level. （Poster notice，General）
7.	2019/05/05	Therapeutic effect of tadalafil in the chronic prostatitis （Poster notice，General）
8.	2019/04/11	The application of color Doppler ultrasonography in patients with ejaculation dysfunction and a male volunteer with the squirting phenomenon after ejaculation: an update （Poster notice，General）
9.	2019/03/17	Changes in circulating blood volume measured by pulse dye-densitometry during preoperative management with an α-blocker in patients with pheochromocytoma （Poster notice，General）
10.	2019/03/17	Therapeutic effect of tadalafil in the chronic prostatitis （Poster notice，General）
11.	2018/09/23	Laparoscopic adrenal-sparing surgery in pheochromocytoma associated with multiple endocrine neoplasia type 2A （Speech，General）
12.	2018/09/20	Therapeutic effect of indoleamine 2,3-dioxygenase (IDO) inhibitor in the male genital inflammation （Speech）
13.	2018/09/19	Therapeutic effect of indoleamine 2,3-dioxygenase (IDO) inhibitor in the male genital inflammation （Poster notice）
14.	2018/09/19	Therapeutic effect of indoleamine 2,3-dioxygenase (IDO) inhibitor in the male genital inflammation （Speech，General）
15.	2018/05/18	Risk of secondary bladder cancer after high dose rate brachytherapy for prostate cancer （Speech，General）
16.	2018/04/19	The role of indoleamine 2,3-dioxygenase (IDO) in prostatitis （Speech，General）
17.	2018/03/17	Therapeutic effect of indoleamine 2,3-dioxygenase inhibitor in epididymitis （Speech，General）
18.	2017/10/19	Prospective study of a switching GnRH agonist therapy in castration resistant prostate cancer in Japanese patients （Poster notice，General）
19.	2017/05/12	Therapeutic effect of indoleamine 2,3-dioxygenase inhibitor in epididymitis （Speech，General）
20.	2017/05/12	Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion （Speech，General）
21.	2017/05/12	Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion （Poster notice，General）
22.	2017/03/24	Therapeutic effect of indoleamine 2,3-dioxygenase inhibitor in epididymitis （Poster notice，General）
23.	2017/03/24	Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion （Speech，General）
24.	2017/01/14	Effects of hydrogen-rich water in a bladder output obstruction (BOO) model （Poster notice，General）
25.	2017/01/14	Effects of microscopic subinguinal varicocelectomy on semen analysis findings and fertility of infertile male patients with varicocele （Poster notice，General）
26.	2016/11/11	Endoscopic removal of Memotherm^R using holmium YAG laser:A report of 3 cases （Poster notice，General）
27.	2016/11/11	Initial experience with the EMARO pneumatic laparoscopic holder robot in laparoscopic urological surgery
28.	2016/11/11	Therapeutic results and complications of ureteroscopic lithotripsy （Poster notice，General）
29.	2016/05/07	Tadalafil for male LUTS improves endothelial function （Speech，General）
30.	2016/05/07	The role of indoleamine 2,3-dioxygenase in epididymitis （Speech，General）
31.	2016/04/02	Effects of microscopic subinguinal varicocelectomy on semen analysis findings and fertility of infertile male patients with varicocele （Speech，General）
32.	2016/04/01	Pilot study of penile brachial index for Erectile Dysfunction （Speech，General）
33.	2016/03/12	The role of indoleamine 2,3-dioxygenase in epididymitis （Speech，General）
34.	2015/02	Evaluation of vascular endothelial function for patients with Erectile Dysfunction （Poster notice，General）
35.	2015/02	Maintenance of oral administration of anticholinergic drugs for overactive bladder （Poster notice，General）
36.	2014/10/23	Change of sexual functions in patients with benign prostatic hyperplasia after holmium laser enucleation of the prostate (HoLEP). （Speech）
37.	2014/09/04	Unilateral adrenalectomy followed by contralateral laparoscopic partial adrenalectomy for men 2a: A report of two cases （Speech，General）
38.	2014/07/21	Characterization of Sterol-Activated Signalling Pathways in Sertoli Cells （Speech，General）
39.	2012/08/04	Analysis of human ejaculation using color Doppler ultrasonography （Speech，Panelist at Symposium/Workshop (Other)）
40.	2011/10/19	Comparison of Two Different Antimuscarinics, Imidafenacin and Solifenacin for Treatment of Overactive Bladder: A Prospective Randomized Controlled Study （Poster notice，General）
41.	2011/10/19	Correlation of Urinary Nerve Growth Factor Level With the Response of Antimuscarinic Therapy in Patients With Overactive Bladder （Poster notice，General）
42.	2011/10/18	Correlation with Urinary Epithelium and Primary Symptoms in Interstitial Cystitis: Inbestigation of Scannin Electron Microscopy （Poster notice，General）
43.	2011/10/18	Risk Factor Analysis of Patients’Dissatisfaction After Holmium LaserEnucleation of the Prostate (HoLEP)for Benign Prostatic Hyperplasia （Poster notice，General）
44.	2011/10/17	Efficacy of Transperineal Versus Transrectal 12-Core Initial Prostate Biopsy with PSA Levels Between 4.0 and 20.0 ng/ml （Speech，General）
45.	2011/10/17	Prognostic Factors and Survival of Renal Cell Carcinoma in Japanese Patients （Poster notice，General）
46.	2011/10/17	Retroperitoneal Dedifferentiated Liposarcoma with Production of Granulocyte Colony-Stimulating Factor (G-CSF) Accompanied by Spontaneous Rupture: PET/CT Imaging of a G-CSF-Producting Tumor （Poster notice，General）
47.	2011/09/01	Comparison of two different antimuscarinics, Imidafenacine and solifenacin, for treatment of overactive bladder: A prospective randomized controlled study （Poster notice，General）
48.	2011/08/31	Correlation of urinary nerve growth factor level with the response of antimuscarinic therapy in patients with overactive bladder （Poster notice，General）
49.	2011/08/31	Correlation with urinary epithelium and primary symptoms in interstitial cystitis: investigation of scanning electron microscopy （Poster notice，General）
50.	2010/07/09	Function of Prostate in Ejaculation （Speech，Panelist at Symposium/Workshop (Other)）
51.	2009/11/03	Does transection of the spermatic cord lower the incidence of inguinal hernia after radical retropubic prostatectomy? （Poster notice，General）
52.	2009/11/01	The Effects of 3 Types of Alpha1-Adrenoceptor Blockers on Lower Urinary Tract Symptoms and Sexual Functions in Men with Benign Prostatic Hyperplasia
53.	2008/09/20	Clinical outcome in patients with locally and locally advanced prostate cancer treated with high-dose-rate brachytherapy. （Speech，General）
54.	2008/09/20	Optimal approach for prostate cancer detection as initial biopsy:A prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. （Speech，General）
55.	2007/11/17	IRIDIUM-192 HIGH-DOSE-RATE BRACHYTHERAPY FOR T1c-T3bN0M0 PROSTATE CANCER （Speech）
56.	2007/09/02	IRIDIUM-192 HIGH-DOSE-RATE BRACHYTHERAPY FOR T1c-T3bN0M0 PROSTATE CANCER （Speech，General）
57.	2007/05/19	Correlation　of urinary nerve growth factor level with pathogenesis of overactive bladder （Poster notice）
58.	2007/05/19	Ejaculatory dysfunction caused by new A1-blocker: analysis of human ejaculatory phenomenon using color doppler ultrasonography （Speech）
59.	2006/09/15	The experience of using dual lumen ureteral access sheath (AquaGuideTM) in ureteropyeloscopy （General）
60.	2004/10/03	What is the neurovascular bundle in urologic surgery? -tha discrepancy between the classical concept and recent findings-. （General）
Display 5 items
Display all(60)